Alnylam Pharmaceuticals, Inc. (ALNY)

336.19 -3.18 (-0.94%) USD  |  NASDAQ  |  Feb 20, 16:00
337.00 +0.81 (+0.24%) After-Hours: 20:00
More

Alnylam Pharmaceuticals EPS Diluted from Extraordinaries (Quarterly)

EPS Diluted from Extraordinaries (Quarterly) Chart

View EPS Diluted from Extraordinaries (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Extraordinaries (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years

View EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Extraordinaries (Quarterly) Benchmarks

View EPS Diluted from Extraordinaries (Quarterly) Benchmarks
Start Trial
Insmed, Inc. --
Biogen, Inc. --
Pfizer Inc. --
Eli Lilly & Co. --
AbbVie, Inc. --